👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 97/100
Accepting new patients
Dr
Dr Varun Mehra
Haematology
English
Hindi
Punjabi
5,086+
Patients seen
2
Years in practice
9
Publications
3
Languages spoken
About
Dr Varun Mehra is a leading consultant haematologist based in London. He specialises in myelodysplastic syndrome, acute leukaemia, bone marrow failure syndromes, autologous transplantation for autoimmune conditions such as multiple sclerosis, Crohn's disease, systemic sclerosis, and has expertise in allogeneic stem cell transplantation, immunotherapy and post transplant complications.
Dr Mehra completed his post-graduate specialist Haematology training at world renowned King's College Hospital, London, where he has been working for past few years as a core member of a busy Stem Cell Transplant & Cellular therapy unit, while pursuing his MD (res) degree with King's College London University in developing novel diagnostic biomarkers for invasive fungal disease (aspergillosis) in immunocompromised Haemato-oncology patients.
Dr Mehra has been instrumental in leading a large single centre NCRN badged prospective study on Invasive Fungal disease and has a good track record for his involvement in clinical trials, more recently as Chief and Principal Investigator of various clinical research studies in the UK. He has developed key academic partnerships in mycology research and education within Kings Health Partners (KHP). He has published regularly with more than 90+ publications on his disease specific research interests in high impact clinical and scientific journals. He is also Faculty editor for a popular Haematology book series- Crash Course Book in Haematology and Immunology 6th edition.
Dr Mehra's main research interests are in infections of immunocompromised hosts, graft versus host disease and transplantation of autoimmune diseases; and have helped develop exciting research collaborations within and outside Kings Health Partners with bench to bed translation opportunities.
He also has strong interest in education and training. He chaired London School of Pathology Specialist Trainee Committee and represented London Pathology Trainees in the Royal College Specialist Advisory group between 2014-2016. He currently sits on the KHP Institute of Haematology Education & Training steering group, playing an active role in developing post-graduation modules for training in clinical haematology and other disease specific Preceptorship programs.
Dr Mehra is also fully trained in the assessment of patients for, and delivery of CAR-T therapy, a highly specialised new therapy that has recently been licensed for certain patients with relapsed high grade B cell lymphomas and acute lymphoblastic leukaemia.
Dr. Mehra has expertise in the following areas:
• Autologous and Allogeneic Stem cell Transplants
• Chemotherapy, Immunotherapy and Cellular therapy
• Transplants (HSCT) in Multiple Sclerosis and Autoimmune disorders
• Second Opinions
• Graft versus Host disease
• Acute Leukaemia
• Myelodysplastic syndromes
• Myeloproliferative disorders
• Bone Marrow Failure
• Aplastic Anaemia
• Multiple Myeloma
• Lymphoma and chronic lymphoproliferative disorders
• Low/High Platelets disorders
• Haemochromatosis/ Iron deficiency
Dr Mehra completed his post-graduate specialist Haematology training at world renowned King's College Hospital, London, where he has been working for past few years as a core member of a busy Stem Cell Transplant & Cellular therapy unit, while pursuing his MD (res) degree with King's College London University in developing novel diagnostic biomarkers for invasive fungal disease (aspergillosis) in immunocompromised Haemato-oncology patients.
Dr Mehra has been instrumental in leading a large single centre NCRN badged prospective study on Invasive Fungal disease and has a good track record for his involvement in clinical trials, more recently as Chief and Principal Investigator of various clinical research studies in the UK. He has developed key academic partnerships in mycology research and education within Kings Health Partners (KHP). He has published regularly with more than 90+ publications on his disease specific research interests in high impact clinical and scientific journals. He is also Faculty editor for a popular Haematology book series- Crash Course Book in Haematology and Immunology 6th edition.
Dr Mehra's main research interests are in infections of immunocompromised hosts, graft versus host disease and transplantation of autoimmune diseases; and have helped develop exciting research collaborations within and outside Kings Health Partners with bench to bed translation opportunities.
He also has strong interest in education and training. He chaired London School of Pathology Specialist Trainee Committee and represented London Pathology Trainees in the Royal College Specialist Advisory group between 2014-2016. He currently sits on the KHP Institute of Haematology Education & Training steering group, playing an active role in developing post-graduation modules for training in clinical haematology and other disease specific Preceptorship programs.
Dr Mehra is also fully trained in the assessment of patients for, and delivery of CAR-T therapy, a highly specialised new therapy that has recently been licensed for certain patients with relapsed high grade B cell lymphomas and acute lymphoblastic leukaemia.
Dr. Mehra has expertise in the following areas:
• Autologous and Allogeneic Stem cell Transplants
• Chemotherapy, Immunotherapy and Cellular therapy
• Transplants (HSCT) in Multiple Sclerosis and Autoimmune disorders
• Second Opinions
• Graft versus Host disease
• Acute Leukaemia
• Myelodysplastic syndromes
• Myeloproliferative disorders
• Bone Marrow Failure
• Aplastic Anaemia
• Multiple Myeloma
• Lymphoma and chronic lymphoproliferative disorders
• Low/High Platelets disorders
• Haemochromatosis/ Iron deficiency
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Varun Mehra
Education & training
-
2014–2020 MD · Medicine and Surgery
-
2020–2024 Residency · Haematology
Career & appointments
-
2024-09–2025-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Haematology
Malpractice insurance:
AmTrust Europe · 2,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 1,765 |
| Annual physical exam | 99395 | 1,827 |
| Vaccination administration | 90471 | 787 |
| Minor procedure (skin) | 17110 | 2,148 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 270.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 360.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 10 · i10: 5
-
Long-term follow-up of Haematology across GB
DOI: 10.3527/euroclin.2026.0 · PMID: 32763990 · cited by 13
-
Validation of clinical scoring in Haematology
DOI: 10.5360/euroclin.2025.1 · PMID: 37867160 · cited by 31
-
Long-term follow-up of Haematology across GB
DOI: 10.8856/euroclin.2024.2 · PMID: 30747420 · cited by 113
Invited talks
- Practical updates in Haematology European Annual Congress (Haematology) · Vienna · 2024 · invited
- Single-centre experience in Haematology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Haematology — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Society memberships
- WONCA Europe — Family Doctors — Member · since 2025
- national college of family doctors — Member · since 2025
- European Union of Medical Specialists (UEMS) — Member · since 2025
Patient reviews
- Bedside Manner
- 5.00
- Knowledge
- 5.00
- Wait Time
- 4.71
- Staff Friendliness
- 4.98
- Ease Of Appointment
- 4.86
- Value For Money
- 4.88
- Would Recommend Pct
- 98
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Haematology
- Awareness When should you see a haematology?
For international patients
- Coordinator
- Patient liaison · varun.mehra@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
